Please login to the form below

Not currently logged in
Email:
Password:

dimethyl glutamate

This page shows the latest dimethyl glutamate news and features for those working in and with pharma, biotech and healthcare.

Merck gets CHMP backing for long-delayed oral MS drug

Merck gets CHMP backing for long-delayed oral MS drug

competitive landscape" - with oral therapies such as Novartis' Gilenya (fingolimod) and Biogen's Tecfidera (dimethyl glutamate) reaching or near the market.

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics